Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 06/1/18 → 06/1/24 |
Funding
- Intercept Pharmaceuticals Incorporated: $216,368.42
Study Evaluating the Efficacy and Safety of OBeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (REVERSE)
- Chaudhuri, Ajay (PI)
- Talal, Andrew (PI)
Project: Research